Matthew A. Nix, Ph.D. - Publications

Affiliations: 
University of California, Santa Cruz, Santa Cruz, CA, United States 
Area:
Physical chemistry

8/13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, et al. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. PMID 33093202 DOI: 10.1073/pnas.2016093117  0.361
2020 Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Lim SA, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, et al. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32766586 DOI: 10.1101/2020.07.31.231746  0.378
2015 Nix MA, Kaelin CB, Palomino R, Miller JL, Barsh GS, Millhauser GL. Electrostatic Similarity Analysis of Human β-Defensin Binding in the Melanocortin System. Biophysical Journal. 109: 1946-58. PMID 26536271 DOI: 10.1016/J.Bpj.2015.09.005  0.493
2013 Nix MA, Kaelin CB, Ta T, Weis A, Morton GJ, Barsh GS, Millhauser GL. Molecular and functional analysis of human β-defensin 3 action at melanocortin receptors. Chemistry & Biology. 20: 784-95. PMID 23790489 DOI: 10.1016/J.Chembiol.2013.04.015  0.517
2012 Swope VB, Jameson JA, McFarland KL, Supp DM, Miller WE, McGraw DW, Patel MA, Nix MA, Millhauser GL, Babcock GF, Abdel-Malek ZA. Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3. The Journal of Investigative Dermatology. 132: 2255-62. PMID 22572817 DOI: 10.1038/Jid.2012.135  0.425
2011 Semple F, Macpherson H, Webb S, Cox SL, Mallin LJ, Tyrrell C, Grimes GR, Semple CA, Nix MA, Millhauser GL, Dorin JR. Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF European Journal of Immunology. 41: 3291-3300. PMID 21809339 DOI: 10.1002/Eji.201141648  0.319
2008 Kaelin CB, Candille SI, Yu B, Jackson P, Thompson DA, Nix MA, Binkley J, Millhauser GL, Barsh GS. New ligands for melanocortin receptors. International Journal of Obesity (2005). 32: S19-27. PMID 19136986 DOI: 10.1038/Ijo.2008.234  0.466
2007 Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS. A -defensin mutation causes black coat color in domestic dogs. Science (New York, N.Y.). 318: 1418-23. PMID 17947548 DOI: 10.1126/Science.1147880  0.444
Low-probability matches (unlikely to be authored by this person)
2020 Chan LN, Murakami MA, Robinson ME, Caeser R, Sadras T, Lee J, Cosgun KN, Kume K, Khairnar V, Xiao G, Ahmed MA, Aghania E, Deb G, Hurtz C, Shojaee S, ... ... Nix MA, et al. Signalling input from divergent pathways subverts B cell transformation. Nature. PMID 32699415 DOI: 10.1038/S41586-020-2513-4  0.248
2020 Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, Sadras T, Deb G, Winchester J, Cosgun KN, Geng H, Chan LN, Kume K, Miettinen TP, Zhang Y, ... Nix MA, et al. IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. PMID 33149299 DOI: 10.1038/s41586-020-2884-6  0.221
2021 Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, Sadras T, Deb G, Winchester J, Cosgun KN, Geng H, Chan LN, Kume K, Miettinen TP, Zhang Y, ... Nix MA, et al. Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. PMID 33712811 DOI: 10.1038/s41586-021-03388-4  0.121
2021 Nix MA, Mandal K, Geng H, Paranjape N, Lin YT, Rivera J, Marcoulis M, White KL, Whitman JD, Bapat SP, Parker KR, Ramirez J, Deucher A, Phojanokong P, Steri V, et al. Surface proteomics reveals CD72 as a target for in vitro-evolved nanobody-based CAR-T cells in KMT2A/MLL1-rearranged B-ALL. Cancer Discovery. PMID 33727310 DOI: 10.1158/2159-8290.CD-20-0242  0.088
2020 Sarin V, Yu K, Ferguson ID, Gugliemini O, Nix MA, Hann B, Sirota M, Wiita AP. Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis. Leukemia. PMID 32123307 DOI: 10.1016/J.Clml.2019.09.120  0.036
Hide low-probability matches.